期刊文献+

早期高容量血液滤过对重症脓毒症的影响 被引量:5

Early high-volume hemofiltration treatment in severe sepsis
下载PDF
导出
摘要 目的:评价高容量血液滤过(high-volume hemofiltration treatment,HVHF)在早期重症脓毒症患者中的疗效。方法:将30例符合国际诊断标准的重症脓毒症患者纳入本研究,按照脓毒症集束治疗指南进行干预,在确诊24 h内行HVHF治疗,每日连续给予床旁HVHF治疗12~18 h,连续观察72 h。比较治疗前和治疗24 h、48 h、72 h后各时间点动脉血乳酸值、血清细胞因子(IL-6、IL-10)、C反应蛋白(CRP)和氧代谢指标[动脉血pH值、氧和指数(PaO2/FiO2)]等。结果:HVHF治疗24 h、48 h、72 h后脓毒症患者动脉血乳酸值和血清IL-6均明显降低(P〈0.05),IL-10无明显变化(P〉0.05),CRP在HVHF治疗48 h后显著下降,氧代谢指标得到明显改善(P均〈0.05)。结论:HVHF可通过清除血乳酸、促炎因子,减轻脓毒症患者过度的炎症反应,改善组织细胞的氧代谢。 Objective: To evaluate the effect of early application of high-volume hemofiltration treatment(HVHF)on the levels of lactic acid,pro-inflammatory cytokines and C-reactive protein(CRP) in plasma,as well as APACHEⅡscore in patients suffering from severe sepsis.Methods: Thirty patients meeting the diagnosis of severe sepsis were enrolled in the trial within 24 hours of insults.The level of lactic acid,interleukin-6(IL-6) and CRP in plasma were measured before HVHF and at 24,48 or 72 h following HVHF treatment.Results: The plasma levels of lactic acid and IL-6 decreased significantly at 24 h,48 h,72 h after HVHF(P0.05),while,IL-10 did not differ significantly following HVHF(P0.05),when compared with that before HVHF.Conclusion: The early application of HVHF could clear the plasma lactic acid and pro-inflammatory cytokines,and improve the tissue oxygenation in severe sepsis.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2010年第5期483-486,共4页 Journal of Zhejiang University(Medical Sciences)
关键词 脓毒症/治疗 血液滤过/方法 白细胞介素-6/血液 白细胞介素-10/血液 乳酸/血液 Sepsis/therapy High-volume hemofiltration/methods Lactic acid/blood IL-6/blood IL-10/blood
  • 相关文献

参考文献1

二级参考文献10

  • 1Khwannimit B, Bhurayanontachai R. The epidemiology of, and risk factors for mortality from severe sepsis and septic shock in a tertiary - care university hospital setting [ J ]. Epidemiol Infect, 2009, 137 (9): 1333-1341.
  • 2Bellomo R, Baldwin I, Ronco C. High - volume hemofihration [ J ]. Contrib Nephrol, 2001, (132): 375-382.
  • 3Rogiers P. High -volume hemofihration in septic shock [ J ]. Crit Care, 2005, 9 (4): 329-330.
  • 4Bone RC, Sibbald WJ, Sprung CL. The ACCP - SCCM consensus conference on sepsis and organ failure [J]. Chest, 1992, 101 (6) : 1481 - 1483.
  • 5Seeling M, Eggers V, Spies C. Surviving Sepsis Campaign: guideline clarification [J]. Crit Care Med, 2008, 36 (8): 2490 - 2491.
  • 6Boussekey N, Chiche A, Faure K, et al. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock [ J ]. Intensive Care Med, 2008, 34 (9): 1646-1653.
  • 7Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short - term, high - volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock [J]. Crit Care Med, 2000, 28 (11): 3581 -3587.
  • 8Joannes BO, Rapaport S, Bazin R, et al.Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock [ J ]. ASAIO, 2004, 50 (1): 102-109.
  • 9薛骏,刘骏峰,李铭新,施雪枫,丁峰,陆福明,顾勇,林善锬.CVVH疗法对全身炎症反应综合征及脓毒血症患者内皮功能损伤标志物的影响[J].中国血液净化,2007,6(10):545-547. 被引量:11
  • 10李冰,沈洪.脓毒症与凝血功能异常[J].中国全科医学,2008,11(9):781-784. 被引量:5

共引文献6

同被引文献54

  • 1刘雪峰,李文放,赵良,林兆奋.血必净注射液对重症监护病房严重脓毒症患者器官功能保护作用的临床研究[J].中国中西医结合急救杂志,2010,17(1):20-23. 被引量:56
  • 2俞兴群,侯勇,李远思,聂卫群,林燕林,洪峰,高志凌,王龙梅,许绍珍.益气活血法为主治疗全身炎症反应综合征的临床研究[J].中国中西医结合急救杂志,2010,17(2):73-75. 被引量:13
  • 3刘长文,郑永科,陆骏,朱克毅,胡炜,胡伟航.高容量血液滤过对脓毒症合并急性呼吸窘迫综合征血流动力学和氧代谢的影响[J].中国危重病急救医学,2006,18(11):657-660. 被引量:25
  • 4Khwannimit B, Bhurayanontachai R. The epidemiology of, and risk factors for mortality from severe sepsis and septic shock in a tertiary care university hospital setting[J]. Epidemiol Infect, 2009,137(9) : 1333-1341.
  • 5Levy MM,Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS international sepsis definitions conference [J]. Crit Care Med,2003,31(4):1250-1256.
  • 6Pinsky MR. Sepsis:a pro- and anti-inflammatory disequilibrium syndrome[J]. Contrib Nephroi,2001, (132) : 355-366.
  • 7Bellomo R, Baldwin I, Ronco C. High-volume hemofihration [J]. Contrib Nephrol,2001 ,(132) :375- 382.
  • 8Bozza FA, Bozza PT, Castro Faria Neti HC. Beyond sepsis pathopysiology with cytokines what is their value biomarkers for disease severity[J]. Mern Inst Oswaldo Cruz, 2005,100(Suppl 1) :217-221.
  • 9Sander A, Armbruster W, Sander B, et al. Hemofiltration increase clearance in early systemic inflammatory response syndrome but does not aiter and a plama eoneentrations[J]. Intensive Care Med,1997,23(8):878 881.
  • 10Cole L, Bellomo R, Hart G, et al. A phase Ⅱ randomized,controlled trial of continuous hemofiltration in sepsis[J]. Crit Care Med,2002,30(1) :100-106.

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部